ArticleDigestive diseases and sciences2025

Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.

Lisa M A van Lierop et al.PubMed ↗Publisher ↗

No numbers read from the abstract.